Stocks and Investing
Stocks and Investing
Tue, October 16, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, October 15, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Robert Driscoll Upgraded (ABUS) to Hold and Held Target at $5 on, Oct 15th, 2018
Robert Driscoll of Wedbush, Upgraded "Arbutus Biopharma Corporation" (ABUS) to Hold and Held Target at $5 on, Oct 15th, 2018.
Robert has made no other calls on ABUS in the last 4 months.
There is 1 other peer that has a rating on ABUS. Out of the 1 peers that are also analyzing ABUS, all agrees with Robert's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Madhu Kumar of "B. Riley Securities" Maintained at Hold with Increased Target to $12 on, Monday, August 13th, 2018